510(k) K924006

BARTEL PRIMA SYSTEM INFLUENZA A ENZYME IMMUNOASSAY by Baxter Healthcare Corp — Product Code GNX

K924006 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "BARTEL PRIMA SYSTEM INFLUENZA A ENZYME IMMUNOASSAY". The FDA issued a decision of Substantially Equivalent on Dec 29, 1992. The device falls under product code GNX (Antigens, Cf (Including Cf Control), Influenza Virus A, B, C), a Class I device regulated under 21 CFR 866.3330. Baxter Healthcare Corp has 507 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 29, 1992
Date Received
Aug 10, 1992
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Antigens, Cf (Including Cf Control), Influenza Virus A, B, C
Device Class
Class I
Regulation Number
866.3330
Review Panel
MI
Submission Type
510(k) Exempt

Need the full FDA record for Baxter Healthcare Corp? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K924006. Report a data issue: hello@regdatalab.com.